Somaxon Pharmaceuticals to Present at the Oppenheimer 20^th Annual Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Richard W. Pascoe, Somaxon’s president and chief executive officer, will present a company overview at the Oppenheimer 20^th Annual Healthcare Conference at the Waldorf-Astoria Hotel in New York City on Wednesday, November 4th at 4:30 P.M. Eastern Time.

A live webcast of the presentation will be available in the Investor Relations section of the company’s Web site under Event Scheduler at www.somaxon.com. The webcast will be archived and accessible for at least 14 days.

About Somaxon Pharmaceuticals

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxon has submitted a New Drug Application for its product candidate, Silenor^® (doxepin), to the U.S. Food and Drug Administration.

For more information, please visit the company’s web site at www.somaxon.com.